APTAMATRIX, INC. — Department of Health and Human Services SBIR Phase I: 400
APTAMATRIX, INC. — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $176,785
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- Topic
- 400
- Solicitation
- PA14-071
- NAICS
- —
- Place of performance
- NY
- Period
- 2016-07-01 → 2017-12-31
Description
DESCRIPTION provided by applicant Aptamers are nucleic acid based andquot probeandquot molecules that provide similar affinity and specificity as antibodies towards protein targets Aptamers have found utility in a wide variety of diagnostic and therapeutic applications In AptaMatrix In helped pioneer a new method for discovering aptamer probes called Acyclic Identification of Aptamer AIA that leveraged the sequencing capacity of Illumina high throughput sequencing platforms This Phase I SBIR project is focused on further improving the AIA method by integrating a post sequencing Illumina protein screening step secondary screen into the AIA workflow We have established three project aims to successfully complete this project within the Illumina flowcell test optimize a novel method for generating truncated single stranded DNA ssDNA clusters needed for optimal target protein binding on the sequencing system integrate and optimize established protocols and software needed to image DNA protein binding and validate the complete method by monitoring DNA protein binding affinities using a well characterised thrombin thrombin binding aptamer TBA DNA library system Completion of this project will establish a robust and highly valuable platform for rapid and highly efficient aptamer discovery and assessment In Phase II we plan to scale up this method on our GAiix platform to offer rapid aptamer discovery services and consider purchasing a next generation Illumina sequencing platform to implement protein imaging capabilities to accommodate higher sample throughput at a lower operational cost PUBLIC HEALTH RELEVANCE Aptamers are nucleic acid based andquot probeandquot molecules that provide similar affinity and specificity as antibodies towards protein targets This Phase I SBIR project is directed at improving AptaMatrixandapos s AIA aptamer discovery approach by integrating a post sequencing protein imaging on an Illumina sequencing platform